Home > News 

Alzheimer’s Drug Breakthrough Shows Importance of Continued Research

Alzheimer’s Drug Breakthrough Shows Importance of Continued Research

1 minute read

This morning, BBC News reported on a new Alzheimer’s drug, lecanemab, that has been found in trials to slow destruction of the brain, ending years of a “100% failure rate” with Alzheimer’s therapies.

The large-scale trial of the drug involved 1,795 volunteers with early-stage Alzheimer’s who were given infusions of lecanemab every fortnight.

Not only is this a great success for the development of new Alzheimer’s therapies but shows the importance of continued research and having willing research volunteers.

There are many opportunities available across the country and in Oxfordshire to support ongoing research. You can find out more about available research opportunities and what it’s like to take part, here.

Upcoming events

Leave a comment

More news

New support service for anyone who has served in armed forces The Royal British Legion is now providing an Admiral Nurse (specialist dementia nurse) in...

A dementia round table discussion To mark Dementia Action Week 2025, BBC Radio Oxford asked Dementia Oxfordshire to host a ’round table’ discussion. Dementia Adviser...

Planning ahead – and why it matters for everyone Whilst many of us will live longer than our parents’ generation, most of us will live...